Business Context and Reporting Period
This Form 8-K was filed by PluriStem Life Systems, Inc. (referred to as Pluri Inc. in metadata) on October 20, 2005. The company is incorporated in Nevada and operates from Haifa, Israel. The report discloses the entry into a material definitive agreement regarding the global distribution of joint project products in the field of serum-free media for hematopoietic and mesenchymal stem cells.
Key Financial Metrics
The filing does not provide comprehensive financial statements, revenue, profit, cash flow, margins, debt, or liquidity metrics. The only specific financial figure disclosed relates to the new consulting agreement:
- Consulting Retainer: US$1,500 per month.
- Agreement Term: Initial term of six months with automatic monthly renewal.
Material Changes
The primary material change is the execution of a Consulting Agreement dated April 1, 2005, with Biological Industries, Ltd. This agreement establishes a partnership to distribute products utilizing PluriStem's patented PluriX TM bioreactor. Biological Industries, a privately-held biotechnology manufacturer, will provide consulting services through its R&D Manager, Mr. David Fiorentini.
Outlook, Risks, and Management Commentary
Management commentary is limited to the description of the strategic partnership. The agreement aims to leverage Biological Industries' international export network (30 countries) and expertise in animal cell culture products to distribute PluriStem's serum-free media solutions. No specific financial guidance, risk factors, or contingencies are detailed in this specific filing.
Investor Verification Checklist
- Verify the commercial viability and regulatory status of the joint serum-free media products.
- Confirm the extent of Biological Industries' distribution capabilities in target markets.
- Review the full text of the Consulting Agreement (Exhibit 10.1) for termination clauses or additional obligations beyond the retainer fee.
- Check subsequent filings for updates on the performance of the partnership and any additional financial commitments.